Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Congy

Showing results (131-140 of 150) with videos related to

Pageof 15
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 16, 2019
Outcome of Liver Transplant Patients With Preformed Donor-Specific Anti-Human Leukocyte Antigen AntibodiesArnaud Del Bello, Martine Neau-Cransac, Laurence Lavayssiere, et al.
Ebiomedicine|May 13, 2022
Monocytes are the main source of STING-mediated IFN-α productionNicolas Congy-Jolivet, Claire Cenac, Jérôme Dellacasagrande, et al.
Kidney International Reports|August 11, 2020
A Randomized Prospective Study Comparing Anti-T-Lymphocyte Igs to Basiliximab in Highly Sensitized Kidney Transplant PatientsNassim Kamar, Benoit Lepage, Lionel Couzi, et al.
Clinical Transplantation|August 2, 2019
Anti-IL-2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid-term outcomes after ABO-incompatible kidney transplantationArnaud Del Bello, Gillian Divard, Julie Belliere, et al.
Transplantation|February 25, 2012
Anti-human leukocyte antigen immunization after early allograft nephrectomyArnaud Del Bello, Nicolas Congy, Federico Sallusto, et al.
Scientific Reports|May 30, 2019
Cynomolgus macaque IL37 polymorphism and control of SIV infectionTakashi Shiina, Shingo Suzuki, Nicolas Congy-Jolivet, et al.
Transplant Immunology|March 20, 2026
Anti-lymphocyte globulin versus anti-thymocyte globulin in kidney transplant patients with preformed donor specific antibodiesNassim Kamar, Nicolas Congy-Jolivet, Sofiane Salhi, et al.
Kidney International Reports|October 21, 2024
Imlifidase in Highly Sensitized Kidney Transplant Recipients With a Positive Crossmatch Against a Deceased DonorNassim Kamar, Dominique Bertrand, Sophie Caillard, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 26, 2012
Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomyArnaud Del Bello, Nicolas Congy-Jolivet, Federico Sallusto, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 1998
SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptorM Rinaldi-Carmona, F Barth, J Millan, et al.
Pageof 15

Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 16, 2019
Outcome of Liver Transplant Patients With Preformed Donor-Specific Anti-Human Leukocyte Antigen AntibodiesArnaud Del Bello, Martine Neau-Cransac, Laurence Lavayssiere, et al.
Ebiomedicine|May 13, 2022
Monocytes are the main source of STING-mediated IFN-α productionNicolas Congy-Jolivet, Claire Cenac, Jérôme Dellacasagrande, et al.
Kidney International Reports|August 11, 2020
A Randomized Prospective Study Comparing Anti-T-Lymphocyte Igs to Basiliximab in Highly Sensitized Kidney Transplant PatientsNassim Kamar, Benoit Lepage, Lionel Couzi, et al.
Clinical Transplantation|August 2, 2019
Anti-IL-2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid-term outcomes after ABO-incompatible kidney transplantationArnaud Del Bello, Gillian Divard, Julie Belliere, et al.
Transplantation|February 25, 2012
Anti-human leukocyte antigen immunization after early allograft nephrectomyArnaud Del Bello, Nicolas Congy, Federico Sallusto, et al.
Scientific Reports|May 30, 2019
Cynomolgus macaque IL37 polymorphism and control of SIV infectionTakashi Shiina, Shingo Suzuki, Nicolas Congy-Jolivet, et al.
Transplant Immunology|March 20, 2026
Anti-lymphocyte globulin versus anti-thymocyte globulin in kidney transplant patients with preformed donor specific antibodiesNassim Kamar, Nicolas Congy-Jolivet, Sofiane Salhi, et al.
Kidney International Reports|October 21, 2024
Imlifidase in Highly Sensitized Kidney Transplant Recipients With a Positive Crossmatch Against a Deceased DonorNassim Kamar, Dominique Bertrand, Sophie Caillard, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 26, 2012
Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomyArnaud Del Bello, Nicolas Congy-Jolivet, Federico Sallusto, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 7, 1998
SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptorM Rinaldi-Carmona, F Barth, J Millan, et al.
Pageof 15